Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Karen Costenbader MD, MPH

Karen H. Costenbader MD, MPH

Director, Lupus Program; Faculty Director, Office of Research Careers; Michael E. Weinblatt, MD Distinguished Chair in Rheumatology; Department of Medicine, Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Karen Costenbader, MD, MPH, is Professor of Medicine at Harvard Medical School and holds the Michael E. Weinblatt, MD Distinguished Chair in Rheumatology in the Division of Rheumatology, Inflammation and Immunity at Brigham and Women’s Hospital in Boston, Massachusetts, where she serves as Director of the Lupus Program.

She is a graduate of Williams College, University of Cambridge, Harvard Medical School, and Harvard School of Public Health, and trained in medicine and rheumatology at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Costenbader’s research investigates the epidemiology and pathogenesis of systemic lupus erythematosus and rheumatoid arthritis in particular.

She is an experienced research mentor for medical students, residents, graduate students in epidemiology, and rheumatology fellows and junior faculty, having trained over 30 doctoral and post-doctoral fellows and faculty. She is PI of the BWH Lupus Registry containing data on more than 2400 patients. She is a co-editor of Arthritis and Rheumatology, the chair of the Medical and Scientific Advisory Council for the Lupus Foundation of America, and currently chair of the National Institutes of Health AMS study section grant review committee.

Disclosures

Dr. Costenbader reports the following:
  • Editing/Authoring/Publishing: American College of Rheumatology; Elsevier, Inc.; UpToDate (Wolters Kluwer Health, Inc.
  • Consulting/Advising: Amgen, Inc.; AstraZeneca; GlaxoSmithKline; Hospital for Special Surgery; Neutrolis
  • Faculty/Instructing/Speaking/Lecturing: Harvard T. H. Chan School of Public Health; New York University - NYU Langone Hospitals
  • Financial Interest (<1%): Alkermes, PLC
  • Governmental Review Process: National Institutes of Health
  • Scientific Advisory Board: Lupus Foundation of America
All of Dr. Costenbader's financial interests were <$5,000 USD for 2022.